Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling

被引:156
作者
Pezet, A [1 ]
Favre, H [1 ]
Kelly, PA [1 ]
Edery, M [1 ]
机构
[1] Fac Med Necker Enfants Malad, INSERM, U344, F-75730 Paris 15, France
关键词
D O I
10.1074/jbc.274.35.24497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prolactin (PRL) has been shown to activate the cytoplasmic tyrosine kinase Janus kinase 2 (Jak2) and the subsequent recruitment of various signaling molecules including members of the signal transducer and activator of transcription family of transcription factors. Recently, an expanding family of cytokine-inducible inhibitors of signaling has been identified that initially included four members: suppressor of cytokine signaling (SOCS)-1, SOCS-2, SOCS-3, and cytokine-inducible src homology domain 2 (SH-2) proteins. The present study analyzes the role of these members in PRL signaling. Constitutive expression of SOCS-1 and SOCS-3 suppressed PRL-induced signal transducer and activator of transcription B-dependent gene transcription, and Jak2 tyrosine kinase activity was greatly reduced in the presence of SOCS-1 or SOCS-3. SOCS-1 was shown to associate with Jak2, whereas SOCS-2 was associated with the prolactin receptor. Co-transfection studies were conducted to further analyze the interactions of SOCS proteins. SOCS-2 was shown to suppress the inhibitory effect of SOCS-1 by restoring Jak2 kinase activity but did not affect the inhibitory effect of SOCS-3 on PRL signaling. Northern blot analysis revealed that SOCS-3 and SOCS-1 genes were transiently expressed in response to PRL, both in vivo and in vitro, whereas the expression of SOCS-2 and CIS genes was still elevated 24 h after hormonal stimulation. We thus propose that the early expressed SOCS genes (SOCS-1 and SOCS-3) switch off PRL signaling and that the later expressed SOCS-2 gene can restore the sensitivity of cells to PRL, partly by suppressing the SOCS-1 inhibitory effect.
引用
收藏
页码:24497 / 24502
页数:6
相关论文
共 26 条
  • [1] Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
    Adams, TE
    Hansen, JA
    Starr, R
    Nicola, NA
    Hilton, DJ
    Billestrup, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1285 - 1287
  • [2] PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation
    Ali, S
    Chen, ZJ
    Lebrun, JJ
    Vogel, W
    Kharitonenkov, A
    Kelly, PA
    Ullrich, A
    [J]. EMBO JOURNAL, 1996, 15 (01) : 135 - 142
  • [3] Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription
    Berchtold, S
    Volarevic, S
    Moriggl, R
    Mercep, M
    Groner, B
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (04) : 556 - 567
  • [4] Berlanga JJ, 1997, J BIOL CHEM, V272, P2050
  • [5] Identification of SOCS-3 as a potential mediator of central leptin resistance
    Bjorbaek, C
    Elmquist, JK
    Frantz, JD
    Shoelson, SE
    Flier, JS
    [J]. MOLECULAR CELL, 1998, 1 (04) : 619 - 625
  • [6] Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
    Bole-Feysot, C
    Goffin, V
    Edery, M
    Binart, N
    Kelly, PA
    [J]. ENDOCRINE REVIEWS, 1998, 19 (03) : 225 - 268
  • [7] Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
    Dey, BR
    Spence, SL
    Nissley, P
    Furlanetto, RW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 24095 - 24101
  • [8] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924
  • [9] Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay
    Goffin, V
    Kinet, S
    Ferrag, F
    Binart, N
    Martial, JA
    Kelly, PA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) : 16573 - 16579
  • [10] Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling
    Helman, D
    Sandowski, Y
    Cohen, Y
    Matsumoto, A
    Yoshimura, A
    Merchav, S
    Gertler, A
    [J]. FEBS LETTERS, 1998, 441 (02): : 287 - 291